These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 26877167)

  • 41. The effects of prion protein proteolysis and disaggregation on the strain properties of hamster scrapie.
    Deleault AM; Deleault NR; Harris BT; Rees JR; Supattapone S
    J Gen Virol; 2008 Oct; 89(Pt 10):2642-2650. PubMed ID: 18796735
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Increased expression of p62/SQSTM1 in prion diseases and its association with pathogenic prion protein.
    Homma T; Ishibashi D; Nakagaki T; Satoh K; Sano K; Atarashi R; Nishida N
    Sci Rep; 2014 Mar; 4():4504. PubMed ID: 24675871
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genesis of mammalian prions: from non-infectious amyloid fibrils to a transmissible prion disease.
    Makarava N; Kovacs GG; Savtchenko R; Alexeeva I; Budka H; Rohwer RG; Baskakov IV
    PLoS Pathog; 2011 Dec; 7(12):e1002419. PubMed ID: 22144901
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Crossing the species barrier by PrP(Sc) replication in vitro generates unique infectious prions.
    Castilla J; Gonzalez-Romero D; Saá P; Morales R; De Castro J; Soto C
    Cell; 2008 Sep; 134(5):757-68. PubMed ID: 18775309
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Scrapie prion protein structural constraints obtained by limited proteolysis and mass spectrometry.
    Sajnani G; Pastrana MA; Dynin I; Onisko B; Requena JR
    J Mol Biol; 2008 Sep; 382(1):88-98. PubMed ID: 18621059
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cell-specific susceptibility to prion strains is a property of the intact cell.
    Herva ME; Weissman C
    Prion; 2012; 6(4):371-4. PubMed ID: 22561192
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prion replication environment defines the fate of prion strain adaptation.
    Katorcha E; Gonzalez-Montalban N; Makarava N; Kovacs GG; Baskakov IV
    PLoS Pathog; 2018 Jun; 14(6):e1007093. PubMed ID: 29928047
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Biochemical properties of highly neuroinvasive prion strains.
    Bett C; Joshi-Barr S; Lucero M; Trejo M; Liberski P; Kelly JW; Masliah E; Sigurdson CJ
    PLoS Pathog; 2012 Feb; 8(2):e1002522. PubMed ID: 22319450
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Stabilization of a prion strain of synthetic origin requires multiple serial passages.
    Makarava N; Kovacs GG; Savtchenko R; Alexeeva I; Budka H; Rohwer RG; Baskakov IV
    J Biol Chem; 2012 Aug; 287(36):30205-14. PubMed ID: 22807452
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Unexposed Secrets of Prion Protein Oligomers.
    Wang G; Wang M; Li C
    J Mol Neurosci; 2015 Aug; 56(4):932-937. PubMed ID: 25823438
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prion infection of mouse neurospheres.
    Giri RK; Young R; Pitstick R; DeArmond SJ; Prusiner SB; Carlson GA
    Proc Natl Acad Sci U S A; 2006 Mar; 103(10):3875-80. PubMed ID: 16495413
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Charge neutralization of the central lysine cluster in prion protein (PrP) promotes PrP(Sc)-like folding of recombinant PrP amyloids.
    Groveman BR; Kraus A; Raymond LD; Dolan MA; Anson KJ; Dorward DW; Caughey B
    J Biol Chem; 2015 Jan; 290(2):1119-28. PubMed ID: 25416779
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Truncated PrP(c) in mammalian brain: interspecies variation and location in membrane rafts.
    Laffont-Proust I; Hässig R; Haïk S; Simon S; Grassi J; Fonta C; Faucheux BA; Moya KL
    Biol Chem; 2006 Mar; 387(3):297-300. PubMed ID: 16542151
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prion protein and metal interaction: physiological and pathological implications.
    Singh N; Das D; Singh A; Mohan ML
    Curr Issues Mol Biol; 2010; 12(2):99-107. PubMed ID: 19767653
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Molecular Mechanism of the Misfolding and Oligomerization of the Prion Protein: Current Understanding and Its Implications.
    Singh J; Udgaonkar JB
    Biochemistry; 2015 Jul; 54(29):4431-42. PubMed ID: 26171558
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tracing conformational transition of abnormal prion proteins during interspecies transmission by using novel antibodies.
    Ushiki-Kaku Y; Endo R; Iwamaru Y; Shimizu Y; Imamura M; Masujin K; Yamamoto T; Hattori S; Itohara S; Irie S; Yokoyama T
    J Biol Chem; 2010 Apr; 285(16):11931-6. PubMed ID: 20177064
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Highly efficient protein misfolding cyclic amplification.
    Gonzalez-Montalban N; Makarava N; Ostapchenko VG; Savtchenk R; Alexeeva I; Rohwer RG; Baskakov IV
    PLoS Pathog; 2011 Feb; 7(2):e1001277. PubMed ID: 21347353
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Heterogeneity and Architecture of Pathological Prion Protein Assemblies: Time to Revisit the Molecular Basis of the Prion Replication Process?
    Igel-Egalon A; Bohl J; Moudjou M; Herzog L; Reine F; Rezaei H; Béringue V
    Viruses; 2019 May; 11(5):. PubMed ID: 31083283
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Region-Specific Sialylation Pattern of Prion Strains Provides Novel Insight into Prion Neurotropism.
    Makarava N; Chang JC; Baskakov IV
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32012886
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vitro amplification of protease-resistant prion protein requires free sulfhydryl groups.
    Lucassen R; Nishina K; Supattapone S
    Biochemistry; 2003 Apr; 42(14):4127-35. PubMed ID: 12680767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.